CloudCath  

San Francisco,  CA 
United States
info@cloudcath.com
https://www.cloudcath.com/
  • Booth: 2432

Every drop of fluid in a catheterized patient gives a window into that patient’s health, but today we simply drain and discard this fluid. CloudCath’s proprietary solution delivers early insights to a patient’s care team through optical spectral analysis of these discarded fluids. Early and actionable insights lead to better health outcomes, better patient experiences, and significant cost savings in high-cost late-stage disease categories. CloudCath Connect™ PD is a Fluid Analytics Health Monitoring system detecting abnormalities of clinical relevance in dialysate effluent, most importantly peritonitis. The CloudCath Connect™ PD System delivers continuous analytics from the comfort of a patient’s home with state-of-the-art technology that integrates seamlessly into the patient’s daily PD protocol. The platform sends real-time notifications to both clinicians and patients to facilitate the patient monitoring of dialysate fluid required for safe home use of PD. Promising early data show patients and clinicians may be alerted to the need for evaluation days before the onset of symptoms, enabling patients to seek early medical intervention, diagnosis, and treatment.


 Products

  • CloudCath Connect PD
    CloudCath Connect™ PD is a Fluid Analytics Health Monitoring system detecting abnormalities of clinical relevance in dialysate effluent, most importantly peritonitis....

  • The CloudCath Connect™ PD System delivers continuous analytics from the comfort of a patient’s home with state-of-the-art technology that integrates seamlessly into the patient’s daily PD protocol. The platform sends real-time notifications to both clinicians and patients to facilitate the patient monitoring of dialysate fluid required for safe home use of PD. 

    Promising early data show patients and clinicians may be alerted to the need for evaluation days before the onset of symptoms, enabling patients to seek early medical intervention, diagnosis, and treatment.


 Additional Info

First-time Exhibitor:
Yes